Microalbuminuria has recently been associated with insulin resistance in both insulin-dependent and non-insulin-dependent (NIDDM) diabetes mellitus. To establish whether microalbuminuria in non-diabetic subjects as well is associated with insulin resistance and associated abnormalities in glucose and lipid metabolism, oral glucose tolerance tests were performed with measurement of urinary albumin excretion rate, lipids and lipoproteins in 582 male non-diabetic first-degree relatives of patients with NIDDM. In addition, insulin sensitivity was assessed in 20 of these subjects with the euglycaemic hyperinsulinaemic clamp technique. Abnormal albumin excretion rate (AER), defined as AER 15-200 ~tg/min, was associated with higher systolic blood pressure (p < 0.05), higher fasting glucose values (p < 0.05), lower HDL-cholesterol (p < 0.05) and lower apolipoprotein A-I (p < 0.05) concentrations than observed in subjects with normal AER. The rate of glucose metabolism was lower in subjects with abnormal compared to subjects with normal albumin excretion rate (38.0 + 2.8 vs 47.3 + 2.4 ~tmol -kg lean body mass-a min-1; p = 0.028). This difference was almost completely accounted for by a reduction in non-oxidative glucose metabolism (17.7+1.9 vs 27.4+2.7 ~tmol. kg lean body mass -1 min-1; p = 0.010), which correlated inversely with the AER (r = -0.543; p = 0.013). These results suggest that in non-diabetic individuals genetically predisposed to NIDDM, abnormal AER is associated with insulin resistance and abnormalities in glucose and lipid metabolism. [Diabetologia (1995) 38:363 -369] Key words Microalbuminuria, insulin resistance syndrome, insulin sensitivity, euglycaemic hyperinsulinaemic clamp.
lin-dependent (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM) microalbuminuria is associated with insulin resistance, hyperinsulinaemia, hypertriglyceridaemia, low HDL-cholesterol concentrations and hypertension, which all are considered features of the insulin resistance syndrome [9] [10] [11] [12] [13] . Since hyperglycaemia can increase albumin excretion rate (AER) in subjects without diabetic nephropathy [14] and induce insulin resistance [15] , it is not known from studies in patients with IDDM or NIDDM whether insulin resistance and increased AER are due to differences in glycaemic control. To test the hypothesis that an increased AER is associated with insulin resistance and abnormalities of glucose and lipid metabolism we compared estimates of insulin sensitivity, glucose tolerance, insulin, lipid and lipoprotein concentrations between non-diabetic subjects AER.
with increased ( > 15 btg/min) and normal
Subjects and methods
The Botnia Study was initiated in 1990 in western Finland, and aimed at identifying genetic and early metabolic defects in persons at increased risk of developing NIDDM. As part of this study we have measured urinary AER in 582 male first-degree relatives of patients with NIDDM. Informed consent was obtained from all subjects, and the study protocol was approved by the local ethic committees. The subjects participated in a 75-g oral glucose tolerance test (OGTT) performed after a 12-h overnight fast. Venous blood samples were taken at -5, 0, 30, 60 and 120 min for determination of plasma glucose and serum insulin concentrations. Area under the glucose and insulin curves were calculated for the glucose tolerance test. Urine was collected during the OGTT (mean + SD; urine volume 170+112 ml) and the AER was determined from timed (154 + 24 min) urine samples. Abnormal AER was defined as 15-200 ~tg/min. In a subset of subjects (n = 87) overnight timed urine samples were collected. The AER measured during the short urine sampling correlated strongly with the AER measured during overnight urine collection (r = 0.59; p < 0.001). Six subjects (two with newly diagnosed NIDDM, two with impaired and two with normal glucose tolerance) with manifest albuminuria (AER > 200 ~g/min) were excluded from the study to avoid inclusion of subjects with kidney disease of nondiabetic origin. Three blood pressure recordings with 5-rain intervals were obtained from the right arm of a sitting person, and the mean value was calculated. The first measurement was performed after 10 min of rest. Waist circumference was measured on standing subjects with a soft tape at the midaxillary line, midway between the lowest rib margin and the iliac crest. Hip circumference was measured over the widest part of the gluteal region [16] . I~an body mass (LBM) was determined using near-infrared spectroscopy with measurement of the layer of the biceps region of the dominant arm using Futrex 5000 equipment (Futrex Inc., Gaithersburg, MD, USA) [17] . The equipment automatically calculates the fat percentage and fatfree mass from an equation which is based on hydrostatically determined body fat. LDL-cholesterol was calculated using the Friedewald formula [18] .Insulin sensitivity was assessed in ten subjects with abnormal AER (33.2 + 3.8; range 18.5 to 51.6 ~tg/min) and in ten subjects with normal AER (6.3 _+ 0.6; range 4.2 to 9.0 ~tg/min) with a euglycaemic hyperinsulinaemic clamp [19] . The AER in these subjects was based on the mean value of the AER in three overnight urine collections. These two groups were matched for age (53.8+3.9 vs 50.5+ 3.3 years), body mass index (25.9 _+ 1.0 vs 26.6 + 0.6 kg. m-2), waist to hip ratio (0.99 + 0.02 vs 0.98 + 0.01), systolic (136 __+ 7 vs 135 + 4 mm Hg) and diastolic (81 + 4 vs 84 + 2 mm Hg) blood pressure. The groups were also identical for a family history of hypertension and prevalence of smokers. Furthermore, physical activity, as estimated from a questionnaire assessing the amount and intensity of daily working and leisure time exercise was identical in the two groups. After three baseline samples had been obtained for measurement of glucose and insulin concentrations, a primed constant infusion of short-acting human insulin (Actrapid; Novo Nordisk Industri, Copenhagen, Denmark) was administered at a rate of 45 mU/min 9 m 2 body surface area for 150 min. The plasma glucose concentration was determined at 5-min intervals, and an infusion of 20 % glucose was adjusted to maintain a constant plasma glucose concentration. Indirect calorimetry was used for 30 min in the ba-C.M. Forsblom et al.: Insulin resistance and AER sal state and during the last 30 min of the clamp to estimate net rates of substrate oxidation [20] . A computerized, open-circuit system was used to measure gas exchange (Deltatrac; Datex, Helsinki, Finland). Non-oxidative glucose metabolism, which mainly (> 90 %) reflects glycogen synthesis in skeletal muscle [21] , was calculated as the difference between total body glucose uptake and glucose oxidation as determined by indirect calorimetry. The constants to calculate glucose, lipid and protein oxidation from gas exchange data are given in the review by Ferrannini [20] . In previous studies, hepatic glucose production as measured with the tritiated glucose technique was almost totally suppressed in non-diabetic first-degree relatives of NIDDM patients under similar experimental conditions [22] . Therefore, hepatic glucose production was considered to be completely suppressed during the insulin clamp in both groups in our study. All results are expressed relative to the LBM.
Analytical methods
Blood glucose during the oral glucose tolerance test was measured by a hexokinase method (Boehringer Mannheim, Mannheim, Germany). Plasma glucose during the euglycaemic clamp was assayed with a glucose oxidase method using a Beckman Glucose Analayzer II (Beckman, Fullerton, Calif., USA). Serum insulin concentration was determined by a double-antibody radioimmunoassay (Pharmacia, Uppsala, Sweden). The sensitivity of the method is 15 pmol/1, and the interassay coefficient of variation was 5 %. Serum total cholesterol, HDL-cholesterol and triglycerides were measured by commercially available kits with Cobas Mira analyzer (Hoffmann-LA Roche, Basel, Switzerland). Apolipoprotein A-I, A-II and B concentrations in plasma were determined by immunoturbidimetric methods (Boehringer GmbH, No 726478 and 726 486; Boehringer Mannheim; Orion Diagnostica, Espoo, Finland). The interassay variations for apolipoprotein A-I, A-II and B were 3.6, 2.1 and 4.9 %, respectively. Urine albumin concentration was determined immunoturbidimetrically [23] . The detection limit for the assay was 5 mg/1 and the interassay coefficient of variance was 7.5 _+ 1%. Urine urea concentration was measured with a commercially available kit using an enzymatic method (Labsystems, Helsinki, Finland).
Statistical analysis
All data are expressed as mean + SEM unless otherwise stated. The significance of the difference between group means was tested with the Mann-Whitney test using a BMDP statistical package (Biomedical Data Processing 1988, Los Angeles, Calif., USA). Correlations were tested by linear regression analysis after log e transformation of AER. A p-value less than 0.05 was considered statistically significant.
Results
Based upon World Health Organization criteria, 30 (5.2%) relatives had previously unknown diabetes and 134 (23.0%) had impaired glucose tolerance. Prevalence of abnormal AER was slightly, although not significantly higher in subjects with NIDDM (10.0%) and impaired glucose tolerance (11.2%) Fig.1 . Glucose metabolism in subjects by albumin excretion rate. Rate of total glucose metabolism (p = 0.028) and glucose storage (p = 0.010) was reduced in subjects with abnormal vs subjects with normal AER than in those with normal glucose tolerance (7.7 %). Non-diabetic subjects with abnormal AER had higher systolic blood pressure (p < 0.05), higher blood glucose (p < 0.05), lower HDL-cholesterol (p < 0.05) and lower apolipoprotein A-I (p < 0.05) concentrations than normoalbuminuric subjects (Table1). Albumin excretion rate correlated positively but weakly with systolic blood pressure (r=0.101; p = 0.018) and 120-min serum insulin concentrations (r = 0.110; p = 0.010). The rate of total glucose disposal was lower in subjects with abnormal compared with subjects with normal AER (38.0+2.8 vs (Fig. 1) , since the rates of glucose oxidation did not significantly differ between the two groups (10.5 + 1:1 and 8.5 + 1.0 ~tmol 9 kgLBM -1 min-1; p = NS). The rate of non-oxidative glucose metabolism correlated inversely with the AER (r = -0.543; p = 0.013) (Fig.2) . Basal rates of lipid oxidation were similar in patients with abnormal and normal AER (1.24• and 1.33• kgLBM -1" rain-l; p = NS) and suppressed to the same degree during the hyperinsulinaemic clamp (0.69 + 0.10 and 0.61 • 0.15 ~mol. kgLBM -1 min-1; p = NS). Similarly, basal rates of protein oxidation did not differ between the two groups (5.73 + 0.81 and 6.20+0.77 gmol. kgLBM -1 min-1; p = NS). Therefore, rates of energy expenditure in the basal state (81.7 + 3.3 and 81.8 + 2.6 J. kgLBM -1 rain-l; p=NS) and during the clamp (87.0+3.4 and 86.0_+ 3.0 J-kgLBM -1 min-1; p = NS) were similar in subjects with abnormal and normal AER.
Discussion
Microalbuminuria is associated with insulin resistance both in patients with NIDDM [11] and IDDM [12] [13] . However, in patients with manifest diabetes, insulin resistance can develop as a consequence of chronic hyperglycaemia and the degree of albumin excretion can vary with the degree of glycaemia [14, 15] . In these patients it may therefore be difficult to draw conclusions on pathogenetic links between insulin resistance and microalbuminuria. Insulin resistance is also a common feature of non-diabetic firstdegree relatives of patients with NIDDM and it is generally thought that this insulin resistance is of genetic origin [22, 24, 25] . This study provides the first evidence that even among these non-diabetic highrisk individuals, insulin resistance is associated with microalbuminuria. The study also demonstrates that this insulin resistance almost exclusively affects the action of insulin on non-oxidative glucose metabolism, i.e. glycogen synthesis in skeletal muscle [21] . Impaired activation by insulin of the key enzyme of this pathway, glycogen synthase, is a consistent finding m insulin-resistant offspring of patients with NIDDM [24, 26] . Further support for the view that this defect may be genetic in origin comes from a study demonstrating impaired action of insulin on glycogen synthase in cultured fibroblasts from patients with NIDDM [27] . Although we did not measure glycogen synthase activity in muscle in this study it can be speculated that an inherited defect in glycogen metabdlism also contributes to insulin resistance in the microalbuminuric patients of this study. The finding of an association between XbaI polymorphism of the glycogen synthase gene and NIDDM, particularly insulin-resistant NIDDM with hypertension, raises interesting possibilities for a genetic control of insulin resistance [28] . Hypertension is also associateM with insulin resistance [29] and in this, and other studies [30, 31] , individuals with abnormal AER h~d higher blood pressure than those with normal AER. Haffner et al. [32] showed that insulin resistance, indicated by elevated fasting insulin concentrations," precedes the development of diabetes and hypertension in a non-diabetic population. Similarly, insulin resistance was also found to predict the development of hypertension and microalbuminuria in NIDDM patients [10] . If the same is true for non-diabetic subjects, insulin resistance in sub-C.M. Forsblom et al.: Insulin resistance and AER jects with microalbuminuria could be partially ascribed to the presence of hypertension. However, the microalbuminuric and normoalbuminuric subjects participating in the clamp study were matched for blood pressure levels, suggesting that microalbuminuria in the absence of hypertension could also be associated with insulin resistance. This does not exclude the possibility that they may have had elevated blood pressure during the night which could only have been detected by 24-h blood pressure monitoring. If the subjects with abnormal AER had demonstrated the fullblown insulin resistance syndrome they also should have presented with abdominal obesity and characteristic lipid disturbances, i. e. high triglyceride and low HDL-cholesterol concentrations. No increase in waist-hip ratio was observed in subjects with abnormal AER and the observed differences in metabolic parameters were unrelated to body mass index (BMI). Nevertheless, subjects with abnormal AER had lower HDL-cholesterol concentrations and lower apolipoprotein A-I concentrations, compared with subjects with normal AER. Interestingly, despite this reduction in HDL-cholesterol, the triglyceride concentrations were similar in the two groups. In general, changes in HDL-cholesterol and triglyceride concentrations in response to metabolic alterations or drugs are opposed but concomitant, appearing together as a couple [33, 34] . There are several potential explanations for the disassociation of HDL and triglyceride responses. First, triglyceride concentrations show larger variability both within and between individuals than HDL-cholesterol concentrations [35] . Therefore, it is easier to detect changes in HDL-cholesterol than in triglyceride concentrations. Although both triglyceride and HDL-cholesterol concentrations are independently related to insulin resistance [36, 37] , recent studies by Blonk et al. [38] suggest a direct role of insulin in the regulating of triglyceride levels but not of HDLconcentrations. Importantly, this effect was thought to be independent of insulin sensitivity. Note that the two groups of the present study did not differ with respect to BMI, waist/hip ratio and fasting insulin, all known to influence triglyceride levels [39] . Several studies have demonstrated that subjects with low HDL but normal triglyceride levels have a high apo A-I fractional catabolic rate [40] [41] [42] . Recently, Horowitz et al. [43] suggested that apo A-I is more loosely bound to HDL and therefore dissociates more readily. Leroy et al. [44] demonstrated that HDL particles, containing only apo A-I (LpA-I), with diameters of 8.8 nm are the least stable particles. Since small LpA-I particles reside between HDL 2 and HDL 3 densities the loss of these particles could explain the decrease of HDL2 and HDL3-cholesterol concentrations. Free apo A-I is cleared by kidneys and this could be accentuated by an abnormal AER. Blades et al. [45] have reported that a high hepatic li-pase activity is associated with low HDL but normal VLDL levels. In addition, there is evidence to suggest that insulin resistance may influence the activity of both lipoprotein and hepatic lipase enzymes [46, 47] . In support of this, we have observed a decrease in lipoprotein lipase/hepatic lipase ratio in insulin-resistant males [48] . In subjects with abnormal AER, the changes in lipolytic enzymes could destabilize HDL particles and promote dissociation of apo A-I resulting in a more rapid clearance of apo A-I.
Earlier reports in non-diabetic populations [30, 49] have shown that microalbuminuric subjects have higher triglyceride concentrations than subjects with normal AER. In these reports there was a more marked difference in insulin concentrations between the normo-and microalbuminuric groups than in the current study, suggesting that the microalbuminuric patients were more insulin resistant. Furthermore, the subjects in the paper by Mykk~inen et al. [49] were 20 years older and had a higher prevalence of hypertension and obesity than the subjects in our study. In consequence, the prevalence of microalbuminuria in their non-diabetic subjects was also much higher (32 %) than the prevalence found in our study population (9 %).
The reported prevalence of microalbuminuria in non-diabetic subjects has varied between 6.3 % and 13.3 % [7, 30, 31, 50] . In our study we used an AER measured from a timed urine sample collected during an OGTT. The same approach has been used in other population studies [7] . In addition to being easy to perform, the circumstances are well standardised and reliable. All subjects are sitting during the OGTT and drinking the same amount of fluid. Values of AER obtained in this way also correlated significantly with AER in overnight urine collections in this study. The logarithm of AER during the OGTT represents a continuum, not a bimodal distribution. Changing the cut-off level for definition of abnormal AER (15ug/min) does not change the results nor the message of the study.
What could explain the association between microalbuminuria and insulin resistance? Two possible sequences of events should be considered. First, in IDDM, microalbuminuria reflects microvascular damage [51] . The disturbance in microcirculation could lead to changes in muscular blood flow and flux through the capillary endothelium. This, in turn, could change muscle fiber type from oxidative type 1 fibers to glycolytic type 2 b fibers, the latter being associated with insulin resistance [52] . On the other hand, insulin resistance is generally accompanied by hyperinsulinaemia and subjects with abnormal AER had higher fasting insulin concentrations. In non-diabetic men, an acute increase in serum insulin concentrations increases the transcapillary escape rate of albumin [53] . Insulin also stimulates the sympathetic nervous system [54] and the increase in catechol-367 amines could influence the intraglomerular pressure by affecting the blood flow to the glomeruli. Although direct experimental proof for either of these two scenarios is lacking, the data demonstrate an association between insulin resistance and its related abnormalities on one side and microalbuminuria as a sign of vascular damage on the other. This could provide an explanation for the association between insulin resistance and cardiovascular disease [55] . Microalbuminuria could help to identify those insulin-resistant individuals who already present with early signs of vascular dysfunction.
